Bulletin
Investor Alert

Sorrento Therapeutics Inc.

NAS: SRNE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 14, 2022, 7:59 p.m.

/zigman2/quotes/205669265/composite

$

4.55

Change

-0.0100 -0.22%

Volume

Volume 36,583

Quotes are delayed by 20 min

/zigman2/quotes/205669265/composite

Previous close

$ 4.33

$ 4.56

Change

+0.23 +5.31%

Day low

Day high

$4.23

$4.58

Open

52 week low

52 week high

$4.23

$17.25

Open

Insider Actions for Sorrento Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/29/2021 Henry H. Ji
See Remarks; Director
10,000   Derivative/Non-derivative trans. at $4 per share. 40,000
09/27/2021 Kim D. Janda
Director
42,357   Disposition at $8.02 per share. 339,703
09/27/2021 Kim D. Janda
Director
7,357   Derivative/Non-derivative trans. at $3.57 per share. 26,264
09/27/2021 Kim D. Janda
Director
35,000   Derivative/Non-derivative trans. at $1.8 per share. 63,000
09/13/2021 Kim D. Janda
Director
8,000   Disposition at $8.04 per share. 64,320
09/13/2021 Kim D. Janda
Director
8,000   Derivative/Non-derivative trans. at $3.5 per share. 28,000
09/03/2021 Robin L. Smith
Director
100,000   Derivative/Non-derivative trans. at $4.89 per share. 489,000
09/03/2021 Robin L. Smith
Director
75,000   Derivative/Non-derivative trans. at $3.95 per share. 296,250
04/12/2021 Kim D. Janda
Director
1,900   Disposition at $6.97 per share. 13,243
04/12/2021 Kim D. Janda
Director
1,900   Derivative/Non-derivative trans. at $3.5 per share. 6,650
03/16/2021 Najjam Asghar
Chief Financial Officer
56,974   Award at $0 per share. 0
12/16/2020 Dorman Followwill
Director
1,000   Disposition at $7.14 per share. 7,140
11/11/2020 Dorman Followwill
Director
1,000   0
03/05/2020 Robin L. Smith
Director
40,000   Acquisition at $2.27 per share. 90,800
09/13/2018 Ally Bridge Group HK Ltd
78,677   Disposition at $4.92 per share. 387,090
09/13/2018 Ally Bridge Group HK Ltd
29,137   Disposition at $5.01 per share. 145,976

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
6 Purchases
2 Sales
235,357
50,357
Last 12 months
8 Purchases
3 Sales
294,231
52,257

Officers and Executives

Dr. Henry H. Ji
Chairman, President & Chief Executive Officer
Mr. Stephen L Klincewicz
VP-Pharmacovigilance & Clinical Operations
Mr. Najjam Asghar
Chief Financial & Accounting Officer, SVP
Dr. Mike A. Royal
Chief Medical Officer
Dr. Shawn Sahebi
Senior Vice President-Strategy & Analytics
Dr. Kim D. Janda
Director
Mr. Jaisim Shah
Director
Dr. Alexis Nahama
Senior Vice President & Head-RTX Program
Mr. Brian Sun
Secretary, Senior VP & General Counsel
Dr. Mark R. Brunswick
Senior Vice President-Regulatory Affairs & Quality
Ms. Elizabeth Adkins Czerepak
Independent Director
Dr. Yue Wu
Independent Director
Mr. Dorman Followwill
Lead Independent Director
Mr. David Lemus
Independent Non-Executive Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.